News for BYTE Acquisition Corp. (BYTS)

Redmond, Washington-based artificial intelligence company Airship AI AISP seems to have quickly made its mark in the AI-driven surveillance technology space sin...

Airship AI Holdings AISP, the Redmond, Washington, artificial intelligence company helping U.S. Homeland Security agencies monitor the nation's border, announce...

FY 2023 Revenue of $12.3 Million with Pipeline of $140 Million Expected to Drive Triple-Digit Revenue Growth and Positive Cash Flow in FY 2024 Backlog Increased to $11.8 Million Driven by...

Airship AI specializes in surveillance solutions for government, law enforcement, military, and commercial enterprises. Find out why AISP stock is a Buy.

Airship AI, a Redmond, Washington, company that works with the US military and law enforcement, saw its stock price soar 200% this week after it announced a DOJ contract. Here's what the company does.

2023 Nasdaq Listing Strategically Positions Company to Accelerate Growth and Revenue, and Product Launches Drive Strong Demand Across Entire Produ...

Airship AI Issues Stockholder Letter and Provides Corporate Update...

In a recent prediction by AllianceBernstein, the value of Bitcoin (CRYPTO: BTC) is expected to reach a new peak of $80,000 by the end of 2024.

Michael Saylor, co-founder of business intelligence company MicroStrategy Inc. (NASDAQ:MSTR), has sold company shares valued at approximately $216 million.

Lee, a renowned bullish strategist, anticipates the S&P 500 to touch 5,200 by the close of the year.

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering. Motus GI Holdings shares dipped 46.5% to $1.15 in pre-market trading. Here are some other stocks moving in pre-market trading.

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in individuals aged 9 years and older.